Cartesian Therapeutics, a biotech seeking to develop mRNA cell therapies for autoimmune diseases, was trading nearly 20% lower early in Tuesday’s trading. 3 July 2024
The US Food and Drug Administration has published product-specific guidance for generics drugmakers with the goal of facilitating pipeline development and promo 19 May 2023
Famed as a great success story of the generics sector in previous decades, Israel’s Teva Pharmaceutical Industries has seen its growth and share price tail off 18 May 2023
The British Generic Manufacturers Association (BGMA) is seeking a judicial review of the decision on the part of the UK government to exclude it from negotiatio 24 April 2023